Detalhe da pesquisa
1.
Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
Ann Surg Oncol
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767803
2.
Early-stage Triple-negative Breast Cancer: Time to Optimize Personalized Strategies.
Oncologist
; 27(1): 30-39, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305094
3.
ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
Ann Surg Oncol
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38833059
4.
Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.
Invest New Drugs
; 41(3): 391-401, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043123
5.
Epilepsy in Qatar: Causes, treatment, and outcome.
Epilepsy Behav
; 63: 98-102, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27588359
6.
Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
Pediatr Blood Cancer
; 62(12): 2162-6, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26179251
7.
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer.
NPJ Breast Cancer
; 10(1): 39, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834621
8.
Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future Directions.
Clin Breast Cancer
; 23(8): 784-799, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336650
9.
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial.
Cancers (Basel)
; 15(13)2023 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444385
10.
Beyond HER2: Targeting the ErbB receptor family in breast cancer.
Cancer Treat Rev
; 109: 102436, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35870237
11.
Impact of TP53 mutations in Triple Negative Breast Cancer.
NPJ Precis Oncol
; 6(1): 64, 2022 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36085319
12.
BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Acad Radiol
; 29 Suppl 1: S35-S41, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272161
13.
Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer.
Clin Cancer Res
; 28(13): 2878-2889, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507014
14.
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer.
Cancers (Basel)
; 14(5)2022 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267631
15.
Online and Social Media Resources for Patients with MDS.
Curr Hematol Malig Rep
; 13(6): 570-575, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30306313
16.
Impact of social media for the hematologist/oncologist.
Semin Hematol
; 54(4): 193-197, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29153080
17.
BCOR and BCORL1 mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomes.
Leuk Lymphoma
; 60(6): 1587-1590, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30618304